Dr. Joe John Stephenson Jr., MD

Dr. Stephenson practices at Prisma Health Greenville Memorial Hospital in Greenville, South Carolina, part of Prisma Health.

Dr. Stephenson's NPI, 1346245552, was assigned on June 15, 2005. Dr. Stephenson graduated from Medical University of South Carolina College of Medicine in 1991. Dr. Stephenson holds South Carolina license 21785.

Dr. Stephenson's primary practice is Prisma Health Greenville Memorial Hospital, at 701 Grove Road, Greenville, SC 29605 in Greenville County. The practice phone is (864) 455-7000.

Dr. Stephenson's primary practice is Prisma Health Greenville Memorial Hospital in Greenville, South Carolina, part of Prisma Health. Dr. Stephenson is also affiliated with Prisma Health Patewood Hospital. The medical group on file is Prisma Health Medical Group. Dmand AI also links Dr. Stephenson to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stephenson practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Stephenson's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Stephenson is licensed in South Carolina.

CMS data shows 791 Medicare services from Dr. Stephenson across 7 procedure codes in 2024, for 415 Medicare patients. Medicare paid $61,768 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 415 Medicare patients who saw Dr. Stephenson in 2024. The largest group is 65 to 74, with 187 patients. 75% of them have cancer, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stephenson's median patient age at 67, with 84% women.

In 2024, Dr. Stephenson wrote 1,511 Medicare Part D claims for 409 patients. 84% of them were for generic drugs. CMS names the drug for 1,226 of them, across 27 drugs with 11 or more claims each, at $2,663,496 in total drug cost. In 2023, CMS named 1,123 claims across 19 drugs.

Dr. Stephenson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stephenson as offering telehealth.

Dmand AI links 30 papers to Dr. Stephenson, published from 2010 to 2025. 2013 was the busiest year, with 5. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Agents and Lung Neoplasms. Dr. Stephenson has published most often in Invest New Drugs. Dr. Stephenson's most frequent co-authors are John Joseph Nemunaitis, MD, Donald Anthony Richards, MD and Howard A. Burris, MD.

Dmand AI links Dr. Stephenson to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases. Open Payments lists research payments to Dr. Stephenson that name 1 trial.

CMS Open Payments shows 354 general payments to Dr. Stephenson from 41 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Pfizer Inc. paid the most, $83,209. It also lists 3 research payments totaling $5,431 from 2017 to 2021, naming 1 clinical trial.

Dr. Stephenson graduated from Medical University of South Carolina College of Medicine in 1991.